TRUVADA Drug Profile, 2023: TRUVADA (emtricitabine; tenofovir

HIV-prevention drug Truvada approved by US truvada TRUVADA is indicated in at-risk adults and adolescents weighing at least 35 kg for pre-exposure prophylaxis to reduce the risk of truvada Adults: The dose of TRUVADA in HIV-1 uninfected adults is one tablet , taken orally

truvada TRUVADA contains the prescription medicines emtricitabine and tenofovir disoproxil fumarate It is not known if TRUVADA for treatment of HIV-1 infection is safe